 DEVON, Pa., April 29, 2021 GLOBE NEWSWIRE -- Zynerba Pharmaceuticals, Inc. Nasdaq: ZYNE, the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters at the Society of Biological Psychiatry SOBP 2021 Virtual Meeting. Both posters will be made available on the Zynerba corporate website at the time of their presentations at 